Mark H. Richmond
Berater bei Bioscience Managers Pty Ltd.
Ursprung des Netzwerks ersten Grades von Mark H. Richmond
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.
19
| Subsidiary | Investment Managers | 19 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.
17
| Extinct | Miscellaneous Commercial Services | 17 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.
15
| Extinct | Miscellaneous Commercial Services | 15 |
Glaxo Group Research Ltd.
3
| Private Company | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark H. Richmond
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ADECCO GROUP AG | Personnel Services | Director/Board Member | |
Rothschild & Co. Asset Management US, Inc.
 Rothschild & Co. Asset Management US, Inc. Investment ManagersFinance Rothschild & Co. Asset Management US, Inc. (R&Co) is an asset management firm headquartered in Stamford, Connecticut. The firm was founded in 1962 and formerly known as Rothschild Asset Management, Inc. They are a wholly-owned subsidiary of Great Lakes Advisors LLC and their ultimate parent is Wintrust Financial Corp. (NASDAQ: WTFC). R&Co provides investment advisory and sub-advisory services on a discretionary basis to a broad range of clients. They also provide non-discretionary investment advice to various wrap model delivery managed account programs. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Other Consumer Services | Corporate Officer/Principal | |
| Melbourne Business School | College/University | Masters Business Admin Masters Business Admin | |
| AFFIMED N.V. | Biotechnology | Chairman Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| SMARTONE TELECOMMUNICATIONS HOLDINGS LIMITED | Wireless Telecommunications | Director/Board Member | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree | |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Founder | |
| McGill University | College/University | Undergraduate Degree Graduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| PYC THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Birmingham | College/University | Doctorate Degree Undergraduate Degree | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Zurich | College/University | Director/Board Member Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of Western Australia | College/University | Doctorate Degree Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Private Equity Investor Chairman Private Equity Investor Private Equity Investor | |
| LaTrobe University | College/University | Undergraduate Degree Graduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
Lipideon Biotechnology AG
 Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
Humanetix Pty Ltd.
 Humanetix Pty Ltd. Packaged SoftwareTechnology Services SmartWard Pty Ltd. develops software for the healthcare industry. The company was founded by Lindsay Bevege in 2012 and is headquartered in Bruce, Australia. | Packaged Software | Director/Board Member Director/Board Member | |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
| REX BIONICS PLC | Medical Specialties | Chief Executive Officer Director/Board Member | |
| ADHERIUM LIMITED | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Wilson Parking New Zealand Ltd.
 Wilson Parking New Zealand Ltd. Other Consumer ServicesConsumer Services Wilson Parking New Zealand Ltd. provides car parking management services. It also provides temporary parking usually on an hourly, daily, or monthly contract or fee basis in garages. The firm also operates car parks in office towers, airports, shopping centres, development sites, special event locations, hospitals, councils and across all of New Zealands main centres. It has offices in Auckland, Christchurch, Dunedin, Hamilton, Tauranga, Wellington, Queenstown and Invercargill. The company was founded in 1990 and is headquartered in Auckland, New Zealand. | Other Consumer Services | Director/Board Member | |
| KUROS BIOSCIENCES AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Chairman Chief Executive Officer | |
Summatix Pty Ltd.
 Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member Director/Board Member Director/Board Member | |
Canary Medical, Inc.
 Canary Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Chief Executive Officer Director/Board Member | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| AVITA MEDICAL, INC. | Medical Specialties | Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigtes Königreich | 18 |
| Schweiz | 11 |
| Australien | 9 |
| Vereinigte Staaten | 7 |
| Deutschland | 5 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 257 |
| Corporate Officer/Principal | 105 |
| Chairman | 67 |
| Independent Dir/Board Member | 51 |
| Chief Executive Officer | 38 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Nicole Vitullo | 29 |
| Michael Perry | 28 |
| Dennis Purcell | 26 |
| Peter Stephen Keen | 25 |
| Thomas O. Hecht | 24 |
| Harry Welten | 22 |
| Bill Hunter | 22 |
| Wolfgang Plischke | 21 |
| Graham K. Crooke | 21 |
| Timothy Harris | 19 |
| Meinhard Folkert Schmidt | 17 |
| David Atkins | 15 |
| Thorlef Spickschen | 14 |
| Barry James Price | 14 |
- Börse
- Insiders
- Mark H. Richmond
- Unternehmensverbindungen
